Rat models are being used in the medical field for a number of purposes such as toxicology, drug development, and various other testing purposes related to the biomedical field. The growing treatment demand for the neurological diseases, cancer, and other diseases along with the emergence of the transgenic rats is anticipated to fuel the global rat model market. In addition to the rat models, the bioinformatics tools and software are used for the analysis of the results obtained from the preclinical tests.

Request for Sample Report @ https://www.zionmarketresearch.com/sample/rat-model-market

The global rat model market is bifurcated on the basis of rat type, service, technology, and application. The rat type segment is divided into outbred, knockout, conditioned, and others. The service segment is categorized based on the cryopreservation, breeding, quarantine, and others. The technology segment is classified into microinjection, embryonic stem cells, and others. The application segment is differentiated into oncology, toxicology, central nervous system, diabetes, immunology and inflammation, and others. The toxicology segment is expected to dominate the global market. The global rat model market was valued at USD 391.7 Million in 2015 and is anticipated to reach up to USD 684.4 Million by 2021, that is, a growth of 9.7% CAGR from 2016 to 2021.

The use of genetically engineered rats for studying the human gene functions or malfunctions propels the global market growth. The use of cryopreservation and embryonic stem cell applications instead of the conventional animal models is helpful in storing the animal cell lines or components for the later purposes. But nowadays, the major concern is the animal cruelty and ethical issues as well as the large-scale use of zebrafish as models, which hinder the growth of the global market. According to an experiment conducted at the Icahn School of Medicine, the researchers from The Seaver Autism Center for Research and Treatment have created and distinguished a genetically modified rat model with autism and intellectual disability that led to the production of the hormone oxytocin and in turn significantly enhanced the nerve cell activity, attention, and social memory.

Browse detail report @ https://www.zionmarketresearch.com/report/rat-model-market

The major leading players include Harlan Laboratories Inc., genOway S.A., Covance, Inc., SAGE Labs, Charles River Laboratories, Biomedical Research Models, Inc., Transviragen Inc., and Transposagen Biopharmaceuticals. On a global basis, North America is expected to be the dominating region followed by Europe and Asia-Pacific.

Advertisements